Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The cancer center was also named one of Working Mother Magazine's 100 Best Companies for 10th time. [53] In 2023, Moffitt was ranked No. 10 in the nation and the top-ranked cancer hospital in Florida and the Southeast in Newsweek’s 2023 list of “America’s Best Cancer Hospitals.” [54]
For premium support please call: 800-290-4726 more ways to reach us
The Dublin, Ohio-based company is the latest to join the trend of healthcare service companies diversifying beyond drug distribution. Rival McKesson recently acquired a unit of Florida Cancer ...
This list comprises the largest companies currently in the United States by revenue as of 2024, according to the Fortune 500 tally of companies and Forbes. The Fortune 500 list of companies includes only publicly traded companies, also including tax inversion companies. There are also corporations having foundation in the United States, such as ...
CG Oncology is one of a handful of companies from the healthcare sector looking to list in the coming months, as a market rally on hopes of a soft landing for the economy eases pressure on ...
Citing a market capitalization of US$67 billion, and stock appreciation of 107%, Celgene was Forbes Magazine's number 2 ranked drug company of 2013. [15] In 2014, Celgene and OncoMed Pharmaceuticals joined a cancer stem cell therapeutic development agreement with demcizumab and five other biologics from OncoMed's pipeline.